Syros Pharmaceuticals, Inc. ( SYRS) - Key Metrics
SYRS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | ? | -$0.16 | -$0.53 | -$0.53 |
| 2024Q2 | ? | -$0.59 | -$0.76 | -$0.76 |
| 2024Q1 | ? | -$0.10 | -$0.80 | -$0.80 |
| 2023Q4 | $0.01 | -$2.18 | -$0.63 | -$0.63 |
| 2023Q3 | $0.13 | -$1.43 | -$1.14 | -$1.14 |
SYRS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -3.30 |
| 2024Q2 | ? | -2.07 |
| 2024Q1 | ? | -13.24 |
| 2023Q4 | ? | -0.89 |
| 2023Q3 | ? | -0.69 |
SYRS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -24.50% | ? |
| 2024Q2 | -15.32% | ? |
| 2024Q1 | -15.83% | ? |
| 2023Q4 | -8.08% | ? |
| 2023Q3 | -28.81% | ? |
SYRS
Price: $0
52 week price:
Earnings Per Share: -3.07 USD
P/E Ratio: -0.01
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 234220
Ebitda: -13.6 millionMarket Capitalization: 5366